+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
ID07813962

Evaluating Dexmedetomidine With or Without Transcutaneous Vagus Nerve Stimulation to Prevent PTSD After Emergency Trauma Surgery

Led by Affiliated Hospital of Nantong University · Updated on 2026-09-17

300

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Emergency trauma surgery patients, such as those injured in car accidents, falls, or engineering accidents, face a much higher risk of developing post-traumatic stress disorder PTSD compared to the general population. PTSD involves intrusive memories, avoidance behaviors, emotional changes, and increased alertness, which can delay psychological recovery, lower quality of life, prolong hospital stays, and increase the risk of readmission. Researchers are studying ways to better prevent PTSD in these patients, as current treatments like dexmedetomidine alone do not fully prevent PTSD and may have side effects like low blood pressure and slow heart rate. The study compares two groups of emergency trauma surgery patients one group receives dexmedetomidine intravenously during surgery at a dose of 0.1 mcgkgh, while the other group receives the same dexmedetomidine treatment combined with transcutaneous vagus nerve stimulation taVNS. The taVNS involves placing electrodes on the ears cavum concha to stimulate the vagus nerve with specific electrical settings. If patients cannot tolerate the stimulation or electrodes fall off, the intervention is adjusted or stopped. This research aims to explore whether combining dexmedetomidine with taVNS improves PTSD prevention. Participants will be followed for one month after surgery, during which researchers will assess the incidence and severity of PTSD using the CAPS-5 scale. Additional evaluations include pain intensity at 24 hours, 48 hours, and one month post-surgery, rates of delirium, nausea, and itching within the first three days, sleep quality, and anxiety levels in the days following surgery. The study uses a randomized, triple-blind design to compare outcomes between groups and monitor safety and treatment effects over this period.

CONDITIONS

Brief Title

Dexmedetomidine Combined With Transcutaneous Vagus Nerve Stimulation (taVNS) Can Reduce the Incidence of PTSD in Trauma Patients After Surgery

Research Team

C

chaochao zhong, Doctor of Medicine

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here